Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Catherine Bollard

Home Clinical Trial Sponsors and OrganizationsCatherine Bollard

Catherine Bollard

5606 Albia Rd, Bethesda, Maryland, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

14

5 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

13

92.9%

Phase 2

1

7.1%

Trial Status Distribution

Active, not recruiting

5

35.7%

Completed

8

57.1%

Recruiting

1

7.1%

Clinical Trials

Trials sponsored by this organization (14)

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

Oct 202112 participants

Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)

Active, not recruiting

Jul 202017 participants

Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)

Active, not recruiting

May 20208 participants

Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma

Active, not recruiting

Jun 201918 participants

HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals

Mar 20197 participants

Multi-antigen T Cell Infusion Against Neuro-oncologic Disease

Active, not recruiting

Dec 201833 participants

Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease

Jun 20181 participant

Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

Active, not recruiting

Jan 20182 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials14
Approvals
News

Back to Organizations